FOCUS aims to solve problems FinOps practitioners face when collecting, normalising and analysing disparate cloud billing data to deliver reports and recommendations on cloud investments. As part of ...

NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentations of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing ...

Presenting Author: Dr. John Foley – Rocky Mountain Multiple Sclerosis, Salt Lake City, Utah Following the presentations, the data presented will be available on the Publications page ...

The Company has been selected to provide an oral presentation featuring clinical data from its ongoing Phase 1 clinical trial of FT819, its off-the-shelf, CD19-targeted, 1XX CAR T-cell product ...

(MENAFN- GlobeNewsWire - Nasdaq) NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentations of data ... the levels of quantitative serum ...

EZCorp runs a resilient, niche pawn lending model with low credit risk and recurring retail revenue. Read why I rate EZPW ...

Rotating between winners and losers using proven models beats buy-and-hold, with SOXL, NVDA, and BVN as recent standouts.

NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentations of data highlighting ... Monitor the levels of quantitative serum immunoglobulins ...

At this year's ASCO meeting, IBI363 reported encouraging Phase 1/2 clinical data in the first three indications explored—non-small cell lung cancer (NSCLC), colorectal cancer (CRC), and melanoma ...